Krosslinker develops patented fabrication technology to manufacture aerogels—light, thermally insulating advanced materials—faster and cheaper with lower energy consumption and a reduced carbon footprint. The company intends to commercialize multiple application-specific aerogel products via its collaborative platform. Krosslinker plans to use recent funding to advance its technology and run pilot trials with customers, with a focus on temperature-sensitive pharmaceutical packaging including potential COVID-19 vaccines. Management has also received interest for high-temperature industrial insulation and automotive uses, specifically insulating EV battery packs against thermal runaway and cold weather. The company was founded in 2019 by a team of three scientists, and Mahesh Sachithanadam is listed as a co-founder and Director of Innovation & Engineering.

Total raised

$1M

Funding rounds

1

Latest round

Seed

Latest activity

Nov 2020